Insider Trades34 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Sell | CTMX | Christopher Ogden | Chief Financial Officer | 1,624 | $3.05 | $788.1M | -55.91% | +110.47% | $5.0K | -0.55% | — | Buy Now |
| Mar 17, 2026 | Sell | CTMX | Christopher Ogden | Chief Financial Officer | 19,323 | $6.42 | $788.1M | -55.91% | +110.47% | $124.1K | -6.11% | — | Buy Now |
| Mar 17, 2026 | Sell | CTMX | Yu-Waye Chu | Chief Medical Officer | 21,279 | $6.42 | $788.1M | -55.91% | +110.47% | $136.7K | -10.10% | — | Buy Now |
| Mar 17, 2026 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 31,492 | $6.42 | $788.1M | -55.91% | +110.47% | $202.3K | -9.48% | — | Buy Now |
| Mar 17, 2026 | Sell | CTMX | Sean A. Mccarthy | CEO | 118,969 | $6.42 | $788.1M | -55.91% | +110.47% | $764.1K | -9.93% | — | Buy Now |
| Nov 6, 2025 | Sell | CTMX | Sean A. Mccarthy | CEO | 101,793 | $4.54 | $788.1M | -55.91% | +110.47% | $461.9K | -9.34% | 10b5-1 | Buy Now |
| Jun 16, 2025 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 13,884 | $2.69 | $788.1M | -55.91% | +110.47% | $37.3K | -4.85% | — | Buy Now |
| Jun 16, 2025 | Sell | CTMX | Sean A. Mccarthy | CEO | 55,511 | $2.69 | $788.1M | -55.91% | +110.47% | $149.3K | -4.85% | — | Buy Now |
| Jun 13, 2025 | Sell | CTMX | Christopher Ogden | Chief Financial Officer | 12,255 | $2.72 | $788.1M | -55.91% | +110.47% | $33.4K | -2.80% | — | Buy Now |
| Mar 18, 2025 | Sell | CTMX | Yu-Waye Chu | Chief Medical Officer | 4,025 | $0.60 | $788.1M | -55.91% | +110.47% | $2.4K | -2.88% | — | Buy Now |
| Mar 18, 2025 | Sell | CTMX | Christopher Ogden | Chief Financial Officer | 8,551 | $0.60 | $788.1M | -55.91% | +110.47% | $5.1K | -4.08% | — | Buy Now |
| Mar 18, 2025 | Sell | CTMX | Lloyd A Rowland | General Counsel | 10,203 | $0.60 | $788.1M | -55.91% | +110.47% | $6.1K | -7.80% | — | Buy Now |
| Mar 18, 2025 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 19,512 | $0.60 | $788.1M | -55.91% | +110.47% | $11.7K | -7.28% | — | Buy Now |
| Mar 18, 2025 | Sell | CTMX | Sean A. Mccarthy | CEO | 37,656 | $0.60 | $788.1M | -55.91% | +110.47% | $22.6K | -3.65% | — | Buy Now |
| Aug 20, 2024 | Sell | CTMX | Christopher Ogden | Chief Financial Officer | 1,984 | $1.23 | $788.1M | -55.91% | +110.47% | $2.4K | -1.80% | — | Buy Now |
| Aug 20, 2024 | Sell | CTMX | Lloyd A Rowland | General Counsel | 4,181 | $1.23 | $788.1M | -55.91% | +110.47% | $5.1K | -3.10% | — | Buy Now |
| Aug 20, 2024 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 4,181 | $1.23 | $788.1M | -55.91% | +110.47% | $5.1K | -2.32% | — | Buy Now |
| Aug 20, 2024 | Sell | CTMX | Jeffrey B Landau | Chief Business Officer | 4,181 | $1.23 | $788.1M | -55.91% | +110.47% | $5.1K | -3.39% | — | Buy Now |
| Aug 20, 2024 | Sell | CTMX | Sean A. Mccarthy | CEO | 13,898 | $1.23 | $788.1M | -55.91% | +110.47% | $17.1K | -2.07% | — | Buy Now |
| Mar 26, 2024 | Buy | CTMX | Sean A. Mccarthy | CEO | 109,768 | $1.57 | $788.1M | -55.91% | +110.47% | $172.9K | +20.93% | — | Buy Now |
| Mar 19, 2024 | Sell | CTMX | Christopher Ogden | SVP, Finance and Accounting | 2,971 | $2.09 | $788.1M | -55.91% | +110.47% | $6.2K | -3.35% | — | Buy Now |
| Mar 19, 2024 | Sell | CTMX | Lloyd A Rowland | General Counsel | 5,268 | $2.09 | $788.1M | -55.91% | +110.47% | $11.0K | -4.28% | — | Buy Now |
| Mar 19, 2024 | Sell | CTMX | Jeffrey B Landau | Chief Business Officer | 6,562 | $2.09 | $788.1M | -55.91% | +110.47% | $13.7K | -5.63% | — | Buy Now |
| Mar 19, 2024 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 12,795 | $2.09 | $788.1M | -55.91% | +110.47% | $26.7K | -7.05% | — | Buy Now |
| Mar 19, 2024 | Sell | CTMX | Sean A. Mccarthy | CEO | 20,223 | $2.09 | $788.1M | -55.91% | +110.47% | $42.2K | -3.71% | — | Buy Now |
| Dec 20, 2023 | Sell | CTMX | Christopher Ogden | SVP, Finance and Accounting | 1,990 | $1.38 | $788.1M | -55.91% | +110.47% | $2.7K | -3.93% | — | Buy Now |
| Dec 20, 2023 | Sell | CTMX | Jeffrey B Landau | Chief Business Officer | 4,077 | $1.38 | $788.1M | -55.91% | +110.47% | $5.6K | -4.50% | — | Buy Now |
| Dec 20, 2023 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 4,077 | $1.38 | $788.1M | -55.91% | +110.47% | $5.6K | -2.56% | — | Buy Now |
| Dec 20, 2023 | Sell | CTMX | Lloyd A Rowland | General Counsel | 4,077 | $1.38 | $788.1M | -55.91% | +110.47% | $5.6K | -3.99% | — | Buy Now |
| Dec 20, 2023 | Sell | CTMX | Sean A. Mccarthy | CEO | 13,551 | $1.38 | $788.1M | -55.91% | +110.47% | $18.7K | -2.89% | — | Buy Now |
| Sep 22, 2023 | Sell | CTMX | Jeffrey B Landau | Chief Business Officer | 4,119 | $1.30 | $788.1M | -55.91% | +110.47% | $5.4K | -5.12% | — | Buy Now |
| Sep 22, 2023 | Sell | CTMX | Marcia Belvin | SVP, Chief Scientific Officer | 4,119 | $1.30 | $788.1M | -55.91% | +110.47% | $5.4K | -2.71% | — | Buy Now |
| Sep 22, 2023 | Sell | CTMX | Lloyd A Rowland | General Counsel | 5,486 | $1.30 | $788.1M | -55.91% | +110.47% | $7.1K | -6.37% | — | Buy Now |
| Sep 22, 2023 | Sell | CTMX | Sean A. Mccarthy | CEO | 14,601 | $1.30 | $788.1M | -55.91% | +110.47% | $19.0K | -3.28% | — | Buy Now |